Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegoprazan DDI with Proguanil in Healthy Volunteers
NCT04568772Phase 1Completed
- Sponsor
- Seoul National University Hospital
- Start
- Nov 2020
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tegoprazan in gastroesophageal reflux disease (GERD) (4 arms), sponsored by Seoul National University Hospital. Primary endpoint: Area Under the Plasma Concentration-Time Curve From Time Zero to the Last Quantifiable Concentration at 48 hours. Started Nov 2020; status: completed.
02
Drugs
tegoprazan
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT04568772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04568772.